Arm Holdings (NASDAQ:ARM) stock fell on Friday, primarily driven by legal uncertainty surrounding its ongoing dispute with Qualcomm (NASDAQ:QCOM). The Nasdaq is up 0.42% while the S&P 500 has gained 0.54% and Technology is higher by 0.4%.

A Delaware jury received the lawsuit filed by Qualcomm against Arm on Friday, according to a report by Reuters. The legal action addresses claims that Arm breached its licensing agreements and intentionally sabotaged Qualcomm’s dealings with Meta Platforms Inc (NASDAQ:META).

Trial Signals Relationship Friction

The five-day federal trial in Wilmington, Delaware, marks the second legal proceeding between the two companies in two years. Tension between the firms intensified after SoftBank Group Corp (OTC:SFTBY) acquired control of Arm in 2016, shifting Arm’s model from licensing chip-making technology to selling its own chips.

At stake is whether Qualcomm, whose architecture license with Arm extends through 2033, can agree to terms for new architecture versions. Qualcomm asked the jury to rule that Arm breached contracts by withholding software patches and design tools, while violating a clause ensuring Qualcomm paid within 10% of the lowest processor design price.

Read Also: US Consumers Expect Inflation at 4.7%: UMich Survey Shows Second-Worst Print Ever

Technical Analysis

From a trend perspective, Arm is still in a longer-term uptrend, trading 21.5% above its 200-day SMA ($220.12), but the near-term picture is choppier. The stock is 7.5% below its 20-day SMA ($288.99) and about 10% below its 100-day SMA ($297.10), which points to a cooling phase after prior strength.

The bigger-picture backdrop is still constructive, with the 50-day SMA above the 200-day SMA (a golden cross that occurred in April), but price is now slightly below the 50-day SMA ($269.89). That combination often creates a "prove it" zone where bulls want a quick reclaim of the 50-day, while bears look for follow-through toward deeper support.

  • Key Resistance: $267.50
  • Key Support: $238

Earnings And Analyst Outlook

Arm is scheduled to report its second-quarter fiscal 2027 earnings on Nov. 4.

Wall Street expects earnings of 48 cents per share, compared with 39 cents a year earlier. Revenue is projected to reach $1.38 billion, up from $1.14 billion in the year-ago quarter.

Meanwhile, Arm trades at a price-to-earnings ratio of 300.4, reflecting high expectations for future growth. The stock carries a consensus Buy rating, with an average price forecast of $272. Recent analyst actions include:

  • Rosenblatt: Maintained Buy, lowered its price forecast from $270 to $250 on July 31.
  • UBS: Maintained Buy, lowered its price forecast from $360 to $320 on July 30.
  • Morgan Stanley: Maintained Equal-Weight, raised its price forecast from $202 to $212 on July 30.

ARM Stock Price Activity: ARM shares are trading lower by 2.75% at $267.72 at the time of publication on Friday, according to Benzinga Pro data.

Read Also: Clover Health Stock Pops: What's Happening?

Image via Shutterstock